Holen Sie sich die Stockscreener-App
1.0099
4.36%
0.0498
Schlusskurs vom Vortag:
$0.9601
Offen:
$0.9838
24-Stunden-Volumen:
5,541
Relative Volume:
0.07
Marktkapitalisierung:
$53.87M
Einnahmen:
$118.18M
Nettoeinkommen (Verlust:
$5.99M
KGV:
7.6566
EPS:
0.1319
Netto-Cashflow:
$-12.91M
1W Leistung:
-2.72%
1M Leistung:
-21.10%
6M Leistung:
-36.30%
1J Leistung:
-38.42%
1-Tages-Spanne:
$0.9838
$0.9938
1-Wochen-Bereich:
$0.872
$1.08
52-Wochen-Spanne:
$0.68
$1.7799
Intercure Ltd Stock (INCR) Company Profile
Vergleichen Sie INCR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INCR
Intercure Ltd
|
0.9851 | 52.50M | 118.18M | 5.99M | -12.91M | 0.1319 |
|
ZTS
Zoetis Inc
|
126.59 | 55.90B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.32 | 51.72B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.925 | 44.71B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.05 | 37.30B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
RGC
Regencell Bioscience Holdings Ltd
|
50.70 | 20.48B | 0 | -5.87M | -767.30K | -0.45 |
Intercure Ltd Stock (INCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-05-18 | Hochstufung | Canaccord Genuity | Speculative Buy → Buy |
Intercure Ltd Aktie (INCR) Neueste Nachrichten
Can InterCure Ltd. stock attract ESG capital inflows2025 Buyback Activity & AI Enhanced Trade Execution Alerts - ulpravda.ru
Will InterCure Ltd. stock attract ESG investorsJuly 2025 Gainers & Smart Swing Trading Alerts - ulpravda.ru
Top Cannabis Stocks To Watch TodayJanuary 1st - MarketBeat
Top Cannabis Stocks To Watch Today – January 1st - Defense World
Wall Street Recap: How InterCure Ltd stock compares to market leadersJuly 2025 Technicals & Stepwise Swing Trade Plans - moha.gov.vn
InterCure (NASDAQ:INCR) Shares Down 6.6% – Should You Sell? - Defense World
InterCure Shareholders Approve All Proposals at 2025 Annual Meeting - TipRanks
InterCure shareholders approve all proposals at 2025 annual meeting - MSN
We Discuss Why InterCure Ltd.'s (TLV:INCR) CEO Compensation May Be Closely Reviewed - simplywall.st
Why InterCure Ltd. stock could see breakout soonInterest Rate Changes & Zero-Cost Stock Research by Professionals - bollywoodhelpline.com
Will InterCure Ltd. stock gain from strong economyMarket Sentiment Extremes & Exceptional Profit Portfolio - bollywoodhelpline.com
Critical Contrast: InterCure (NASDAQ:INCR) & Varex Imaging (NASDAQ:VREX) - Defense World
Is InterCure Ltd. stock a buy for dividend growthJuly 2025 Volume & Verified Stock Trade Ideas - Улправда
How InterCure Ltd. stock compares to market leaders2025 Earnings Surprises & Fast Gaining Stock Strategy Reports - DonanımHaber
Will InterCure Ltd. stock gain from lower inflationDollar Strength & Weekly Market Pulse Updates - DonanımHaber
What valuation multiples suggest for InterCure Ltd. stockEarnings Growth Report & Technical Confirmation Alerts - ulpravda.ru
InterCure Ltd on Dec 15, became aware that Bazelet Group of Companies has initiated Restructuring proceedings before the Israeli district court - marketscreener.com
InterCure Ltd On Dec 15, Became Aware That Bazelet Group Of Companies Has Initiated Restructuring Proceedings Before The Israeli District Court - TradingView — Track All Markets
InterCure Faces NIS 27 Million Exposure as Key Cannabis Partner Bazelet Enters Restructuring - TipRanks
[6-K] Intercure Ltd. Current Report (Foreign Issuer) | INCR SEC FilingForm 6-K - Stock Titan
InterCure (TLV:INCR) shareholders are up 16% this past week, but still in the red over the last five years - simplywall.st
InterCure May Be Uniquely Positioned as Trump’s Cannabis Rescheduling Returns to Headlines (NASDAQ: INCR) - TradingView — Track All Markets
Head to Head Comparison: InterCure (NASDAQ:INCR) and Jushi (OTCMKTS:JUSHF) - Defense World
How interest rate cuts could boost InterCure Ltd. stockJuly 2025 Fed Impact & Community Verified Trade Signals - Newser
How resilient is InterCure Ltd. stock in market downturnsGold Moves & Expert Approved Trade Ideas - Newser
Is InterCure Ltd. stock a buy before product launchesJuly 2025 Decliners & Weekly Top Performers Watchlists - Newser
Will InterCure Ltd. stock see PE expansionGold Moves & Low Drawdown Trading Strategies - Newser
Why InterCure Ltd. stock appeals to dividend seekersTrade Exit Summary & Verified Entry Point Signals - Newser
US Market Wrap: Can InterCure Ltd. stock deliver sustainable ROEJuly 2025 Intraday Action & Weekly Setup with ROI Potential - BỘ NỘI VỤ
Intercure schedules annual shareholder meeting for December 30 in Tel Aviv - Investing.com Nigeria
InterCure Ltd. Schedules Annual General Meeting for December 2025 - TipRanks
Intercure schedules annual shareholder meeting for December 30 in Tel Aviv By Investing.com - Investing.com South Africa
InterCure (NASDAQ:INCR) Shares Up 0.7% – Time to Buy? - Defense World
How InterCure Ltd. stock performs during Fed tightening cyclesWeekly Trading Summary & High Accuracy Trade Alerts - newser.com
Why InterCure Ltd. stock remains undervaluedJuly 2025 Market Mood & Momentum Based Trading Ideas - newser.com
How InterCure Ltd. stock performs in weak economyMarket Activity Recap & Accurate Intraday Trading Signals - newser.com
Can InterCure Ltd. stock beat market expectations this quarterJuly 2025 EndofMonth & Fast Momentum Entry Tips - newser.com
Is it time to cut losses on InterCure Ltd.Earnings Growth Report & Weekly Breakout Stock Alerts - newser.com
Is InterCure Ltd. stock a buy in volatile marketsIndex Update & Advanced Swing Trade Entry Plans - newser.com
How strong is InterCure Ltd. stock revenue growthJuly 2025 Setups & Daily Stock Trend Watchlist - newser.com
Is InterCure Ltd. stock cheap at current valuationJuly 2025 Decliners & Weekly Top Performers Watchlists - newser.com
Will InterCure Ltd. stock recover after recent dropWeekly Trend Summary & Risk Controlled Daily Trade Plans - newser.com
Does InterCure Ltd. stock trade at a discount to peersLayoff News & Long-Term Growth Stock Strategies - newser.com
Finanzdaten der Intercure Ltd-Aktie (INCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.72%
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):